Anticoagulation Center Meet the Experts

Global CV Institute

HOME | ANTICOAG CENTER HOME | FAQ | ABOUT

GCVI’s Anticoagulation Meet the Experts Webinars

Welcome to the GCVI Anticoagulation Center’s Meet the Experts channel! We invite you to both listen to leading ACC and global thought leaders speak on the latest ACC.21 LBCTs and science and engage with those experts through online webinars.

Webinar 1: Stroke in Atrial Fibrillation 03.24.2021
Activities will include lectures, patient cases, and a panel discussion with Dr. Geoff Barnes, Dr. Gregory Piazza, and Dr. Anastasia Armbruster. Topics include: special considerations for anticoag in AF including renal dosing, obesity, and drug-drug interactions; Technology-based interventions to identify/improve anticoag for AF; and Management of anticoag-related bleeding in AF.

Webinar 2: Stroke in Atrial Fibrillation 06.08.2021
Activities will include lectures, patient cases, and a panel discussion with Dr. Megan Coylewright, Dr. Geoff Barnes, and Dr. Fred Kusumoto. Topics include: Screening for AF: new technologies and thresholds for treatment; Comorbid AF and CAD: how to select the best combination of antithrombotic medications; and Left atrial appendage occlusion: selecting the most appropriate patients.

Webinar 3: Stroke in Atrial Fibrillation 09.28.2021
Activities will include lectures, patient cases, and a panel discussion with Dr. Geoff Barnes, Dr. Mintu Turakhia, and Dr. Fred Kusumoto. Topics include: Bleeding Risk and Anticoagulation in Afib; How Much Afib is Enough to Warrant Stroke Prevention; and DOAC use in Special Populations.

Webinar 4: Venous Thromboembolism Treatment 11.02.2021
Activities include lectures, patient cases, and a panel discussion by Dr. Geoff Barnes, Dr. Lana Castellucci, and Dr. Gregory Piazza. Topics include: Avoiding Hospitalization for Low Risk PE and DVT; Secondary VTE Prevention: Who to Treat and What Agents to Use?; and Preventing VTE in COVID-19: What does the Data Tell Us?

* Funded through an Independent Medical Education Grant by Pfizer Inc. This is an independent medical education program supported by an educational grant from Pfizer. All program objectives, content, and activities are overseen by the ACC to ensure alignment with latest evidence and practice guidelines.

« « Back